FDA Brief

Company record

Pfizer

0 FDA warning letters since 2023 and 3 recalls in the last 12 months.

Get an email the day FDA posts anything new about Pfizer.

Recalls

ReportedClassFirmProduct and reason
Oct 28 Class II Pfizer
Drug
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
Oct 28 Class II Pfizer
Drug
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
Sep 23 Class II Pfizer
Drug
Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.
Lack of Assurance of Sterility